399 related articles for article (PubMed ID: 1733228)
1. Buthionine sulfoximine-induced cytostasis does not correlate with glutathione depletion.
Kang YJ; Enger MD
Am J Physiol; 1992 Jan; 262(1 Pt 1):C122-7. PubMed ID: 1733228
[TBL] [Abstract][Full Text] [Related]
2. Cadmium inhibits EGF-induced DNA synthesis but increases cellular glutathione levels in NRK-49F cells.
Kang YJ; Enger MD
Toxicology; 1991 Mar; 66(3):325-33. PubMed ID: 2011856
[TBL] [Abstract][Full Text] [Related]
3. Increased glutathione levels in quiescent, serum-stimulated NRK-49F cells are associated not with a response to growth factors but with nutrient repletion.
Kang YJ; Enger MD
J Cell Physiol; 1991 Aug; 148(2):197-201. PubMed ID: 1679059
[TBL] [Abstract][Full Text] [Related]
4. Exogenous glutathione attenuates the antiproliferative effect of buthionine sulfoximine.
Kang YJ
Toxicology; 1994 Mar; 88(1-3):177-89. PubMed ID: 8160199
[TBL] [Abstract][Full Text] [Related]
5. Buthionine sulfoximine induced growth inhibition in human lung carcinoma cells does not correlate with glutathione depletion.
Kang YJ; Emery D; Enger MD
Cell Biol Toxicol; 1991 Jul; 7(3):249-61. PubMed ID: 1933516
[TBL] [Abstract][Full Text] [Related]
6. Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
Kang YJ
Cell Mol Biol Res; 1995; 41(2):131-6. PubMed ID: 8581064
[TBL] [Abstract][Full Text] [Related]
7. Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation.
Shrieve DC; Harris JW
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1171-4. PubMed ID: 3744936
[TBL] [Abstract][Full Text] [Related]
8. Toxic effects of acute glutathione depletion by buthionine sulfoximine and dimethylfumarate on murine mammary carcinoma cells.
Dethlefsen LA; Lehman CM; Biaglow JE; Peck VM
Radiat Res; 1988 May; 114(2):215-24. PubMed ID: 3375425
[TBL] [Abstract][Full Text] [Related]
9. Buthionine sulfoximine inhibition of cystine uptake and glutathione biosynthesis in human lung carcinoma cells.
Brodie AE; Reed DJ
Toxicol Appl Pharmacol; 1985 Mar; 77(3):381-7. PubMed ID: 3975906
[TBL] [Abstract][Full Text] [Related]
10. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
Bertsche U; Schorn H
Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339
[TBL] [Abstract][Full Text] [Related]
11. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
Shrieve DC; Denekamp J; Minchinton AI
Radiat Res; 1985 Jun; 102(3):283-94. PubMed ID: 4070545
[TBL] [Abstract][Full Text] [Related]
12. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines.
Mistry P; Loh SY; Kelland LR; Harrap KR
Int J Cancer; 1993 Nov; 55(5):848-56. PubMed ID: 8244583
[TBL] [Abstract][Full Text] [Related]
13. Depletion of tumour glutathione in vivo by buthionine sulphoximine: modulation by the rate of cellular proliferation and inhibition of cancer growth.
Terradez P; Asensi M; Lasso de la Vega MC; Puertes IR; Viña J; Estrela JM
Biochem J; 1993 Jun; 292 ( Pt 2)(Pt 2):477-83. PubMed ID: 8503882
[TBL] [Abstract][Full Text] [Related]
14. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
Ali-Osman F; Antoun G; Wang H; Rajagopal S; Gagucas E
Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339
[TBL] [Abstract][Full Text] [Related]
15. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
[TBL] [Abstract][Full Text] [Related]
16. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
Kramer RA; Greene K; Ahmad S; Vistica DT
Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
[TBL] [Abstract][Full Text] [Related]
17. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation.
Hamilos DL; Wedner HJ
J Immunol; 1985 Oct; 135(4):2740-7. PubMed ID: 4031498
[TBL] [Abstract][Full Text] [Related]
18. Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio.
Mitchell JB; Russo A; Biaglow JE; McPherson S
Radiat Res; 1983 Nov; 96(2):422-8. PubMed ID: 6647769
[TBL] [Abstract][Full Text] [Related]
19. The pulmonary effects of buthionine sulfoximine treatment and glutathione depletion in rats.
Coursin DB; Cihla HP
Am Rev Respir Dis; 1988 Dec; 138(6):1471-9. PubMed ID: 3202501
[TBL] [Abstract][Full Text] [Related]
20. Depletion of glutathione by L-buthionine sulfoximine does not promote inactivation of myo-inositol transport in cultured bovine lens epithelial cells.
Cammarata PR; Tse D; Yorio T
Curr Eye Res; 1991 Apr; 10(4):321-30. PubMed ID: 1676962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
